【中医药英文刊巡礼】-《世界中西医结合杂志（英文）》

河北医科大学副校长、传授、博士生导师，以岭药业董事长。1992年开办的石家庄斥地区医药研究所正式开业;2006年..成立北京以岭药业有限公司:2009年被选为中国工程院院士;2012年被评为河北省”巨人规划“首批立异创业团队领武士才:2019年被选为中国中医科学院学部委员。吴以岭一向从事中医络病理论研究，擅长中医络病理论及冠芥蒂、心律失常.慢性心衰、脑中风等各类心脑血管病诊治。

Wu Yiling, is an expert in cardiovascular diseases of traditional Chinese medicine, academician of the Chinese Academy of Engineering, vice president, professor, doctoral supervisor of Hebei Medical University, and chairman of Yiling Pharmaceutical. Shijiazhuang Development Zone Medical Research Institute was established in 1992. ln 2006, Beijing Yiling Pharmaceutical Co, LTD was established, He was elected academician of the Chinese Academy of Engineering in 2009. In 2012, he was named the first batch of leading talents of the innovation and entrepreneurship team of Hebe Province "Giant Plan"; ln 2019, he was elected as a member of the Faculty of China Academy of Chinese Medical Sciences. Wu Yiling has been engaged in the theoretical research of collaterals of Chinese medicine, and is good at TCM collaterals pathology and diagnosis and treatment of coronary heart disease, arrhythmia, chronic heart failure, stroke and other cardio-cerebral vascular diseases.